Apadaz Approval History
- FDA approved: Yes (First approved February 23rd, 2018)
- Brand name: Apadaz
- Generic name: acetaminophen and benzhydrocodone hydrochloride
- Dosage form: Tablets
- Previous name: KP201
- Company: KemPharm, Inc.
- Treatment for: Pain
Apadaz (acetaminophen and benzhydrocodone hydrochloride) is an immediate release combination of acetaminophen and benzhydrocodone, a prodrug of the opioid agonist hydrocodone, indicated for the short-term management of acute pain.
Development History and FDA Approval Process for Apadaz
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.